M2 LAB EVAL PRIMARY

Cards (31)

  • QUANTITATIVE PLATELET TESTS
    Assess the number of platelets

    •NV: 150-400x109/L
    •Thrombocytopenia: decreased in platelets
    •Thrombocytosis: increased in platelets
  • METHODS IN QUANTITATIVE PLATELET TESTS
    Direct Method
    Indirect Method
    Automated Method
  • Direct Method
    Brecker Cronkite Method
    Tocantin's Method
  • Brecker Cronkite Method

    - Reference method
    - Uses phase contrast microscope
    -Diluting fluid: 1% ammonium oxalate
  • Tocantin's Method
    - Uses hematocytometers and thoma pipette
    - Uses simple light microscope
    - Reese and Ecker as diluting fluid
    • Brilliant cresyl blue
    Neutral formalin
    Sodium citrate
    - Count 25 RBC square
    - If low count: use WBC pipette (1:20 dilution)
  • Indirect Method
    - Used for platelet estimation Allows visualization of platelet morphology
    - Fonio's Method and Dameshek Method
    - Fonio's method: 1 OIO should have 3-10 platelets per 100 RBC
  • Automated Method
    - Optical and electrical methods
    - Optical degree of light scattering
  • QUALITITATIVE PLATELET TESTS
    Assess the function of platelets

    - Platelet Adhesion in vitro
    - Abnormal Platelet Retention Test
    - Bleeding Time
    - Clot Retraction Test
    - Platelet Factor III Assay
    - Platelet Factor IV and Beta thromboglobulin Assay
    - Platelet Aggregation Test
    - Platelet Aggregation Patterns
  • Capillary Resistance Test
    - Pressure cuff is used in 100mg/Hg for 5 min, count petechiae after 15-30 minutes
    - Correlated with degree of thrombocytopenia
  • 1+
    0-10Few petechiae on the anterior part of forearm
  • 2+

    10-20Many petechiae on the anterior part of the forearm
  • 3+
    20-50Multiple petechiae over the anterior and the back of the hand
  • 4+
    >50 Confluent petechiae over the anterior and the back of the hand
  • Platelet Retention Test
    - Known as glass bead retention dish
    - EDTA/Heparin
    - Blood is passed thru a tube containing beads then platelets adheres to beads
  • 1st tube:

    Control
  • 2nd tube:
    Platelet count
  • 3rd tube:
    Platelet count; Lower count 75-95% of platelet are lost
  • DECREASE PLATELET RETENTION
    Bernard Soulier
    Glanzmann Thrombasthenia
    vWD
    Chediak-Higashi
    Myeloproliferative disorders
    Uremia
    Aspirin Administration
  • INCREASED PLATELET RETENTION
    ‣ Thrombotic disorder
    ‣ Hyperlipidemia
    ‣ Carcinoma
    ‣ Oral Contraceptives
    ‣ Pregnancy
  • Bleeding Time
    - Time required for blood to stop bleeding
    - Affected if there are congenital platelet problems

    Duke's test
    • Modified Ivy's test
    Modified Simplate Test
  • Duke's test

    - For infants, children
    - Done in earlobes
    - NV: 2-8 min
  • Modified Ivy's test
    Done 5cm below the antecubital fossa with pressure cuff (40-60mmhg)
  • Modified Simplate Test
    Done by making a wound incision of 5mm length and 1mm depth
  • Clot Retraction Test
    - Serum is expressed from the clot
    - Assess function of thrombosthenin
    - Asses entire platelet function and coagulation
    -Abnormal CRT: thrombocytopenia, low and abnormal fibrinogens, paraproteins, Glanzmann’s thrombasthenia
    • Hirshboek Method
    • McFarlane Method
  • Hirshboek Method

    - Uses castor oil
    - After 15-45 min check for dimpling phenomenon
  • McFarlane Method
    - Checked after 1 hour
    - Uses wire loop to check for clot then water bath
    - Blood volume should decrease up to 50%
    - NV: 44-67%
  • Platelet Factor III Assay
    - Platelet phospholipids provides surface to which clotting factors bind
    - Needs patient PPP and PRP
    - Control: Pooled PPP, sample, activators, 0.025M CaCl2
    - Activators: Directly stimulates platelets to produce PF3 Kaolin Epinephrine
  • Platelet Factor IV and Beta thromboglobulin Assay
    - Specimen must be refrigerated prior to testing (4C)
    - Part of alpha granules
    - Used as indicator for platelet activation in Myocardial infarction, diabetes, venous thrombosis Measured through RIA
  • Platelet Aggregation Test

    Uses aggregometer
    Specimen: PRP
  • Platelet Aggregation Test Specimen consideration
    • Fasting at least 8 hrs to avoid lipemic sample
    • Must not be placed in ref to avoid aggregation
    Non hemolyzed to avoid release of ADP
    • No aspirin within 7 days
    • Specimen must be in water bath at pH 6.5 to 8.5
  • Aggregating agents
    ADP
    Collagen
    Epinephrine
    Thrombin
    Ristocetin
    Arachidonic acid